Showing results (1-10 of 86) with videos related to
Sort By:
Pageof 9
Acta Medica Academica|July 3, 2019
Multiple Myeloma Genomics - A Concise ReviewOmar Castaneda, Rachid BazTherapeutic Advances in Hematology|July 12, 2017
The potential of ixazomib, a second-generation proteasome inhibitor, in the treatment of multiple myelomaJason Brayer, Rachid BazBlood Reviews|December 4, 2010
Lenalidomide mode of action: linking bench and clinical findingsFaith Davies, Rachid BazJournal of the Advanced Practitioner in Oncology|September 19, 2024
Individualizing Care for Multiple Myeloma: Navigating Treatment Options and Addressing Patient NeedsBeth Finley-Oliver, Rachid BazDrugs of Today (Barcelona, Spain : 1998)|March 14, 2007
Lenalidomide: the emerging role of a novel targeted agent in malignanciesSujith Kalmadi, Rachid Baz, Anuj MahindraCancer Control : Journal of the Moffitt Cancer Center|June 20, 2020
Quality Improvement at an Academic Cancer Center: Venous Thromboembolism Prophylaxis in Patients With Multiple MyelomaRachid Baz, Roy Furman, Katherine Simondsen, et al.Cancer|August 12, 2004
Prevalence of vitamin B12 deficiency in patients with plasma cell dyscrasias: a retrospective reviewRachid Baz, Carlos Alemany, Ralph Green, et al.Expert Review of Hematology|May 16, 2019
Quality of life in multiple myeloma: considerations and recommendationsSamantha Seitzler, Elizabeth Finley-Oliver, Christine Simonelli, et al.Advances in Hematology|July 31, 2010
State-of-the-Art Management of Complications of Myeloma and Its TreatmentMonique A Hartley-Brown, Daniel M Sullivan, Rachid BazHuman Pathology|December 17, 2008
Clinical significance of cyclin D1, fibroblast growth factor receptor 3, and p53 immunohistochemistry in plasma cell myeloma treated with a thalidomide-based regimenTodd W Kelley, Rachid Baz, Mohamad Hussein, et al.Pageof 9